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ated with enhanced surface expression of glycoprotein (GP) Ilb/llla and P-selectin. In the 
figure, maximum aggregation (ADP ZQIM) is plotted against CRP level. 
Conclusions: In patients with stable angna and combined antiplatelet therapy plasma 
CRP levels do not appreciably correlate with platelet function. 
the first balloon inflation. At the end of the procedure, the coronary flow velocity reserve 
(CFVR=hyperemic APVibaseline APV) was measured after i.c. adenosine (20-4Ol.ig) in 
the recanalized artery. 
Results. During follow-up of 6 months 14 reocclusions (16%) occurred. In patients with 
reocclusion the minimum lumen diameter (MLD) was lower. There was no difference in 
parameters of collateral function, or microvascular function as evidenced by a similar 
CFVR (see Table). The angiographic result remained the best predictor of reocclusion in 
the subgroup analysis of patients with recent and long-term occlusions, and with and 
without regional ventricular dysfunction. 
Conclusion. The risk of reocclusion after recanalization of a TCO was determined by a 
low MLD, but not by the quality of collateral function or microvascular function. 
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1175-179 Preprocedural Levels of C-Reactive Protein, 
Postprocedural Creatin Phosphokinase MB Release, 
and Long-Term Prognosis Following Coronary 
Stenting: Results From the GENERATION Study 
Michael N.&iris, John A. Ambrose, Olga Papadaki, Paraskew Psarogianni, Anastassios 
Lyras, Maria Thoma, Evangelos Tsanis. George Psaltiras, Constantine Fakiolas. 
Evangelos Pissimissis. Christopher Olympios, Stefanos Foussas. Tzanio Hospital, 
Piraeus. Greece, Saint Vincent Hospital, New York, NY 
Background: Elevation of creatin kinase-MB (CK-MB) often occurs after coronary stent- 
ing (CS), but its role on long-term prognosis IS controversial. We evaluated the predictors 
of CK-MB release and Its relationship to long-term outcomes after successful CS in 
patients enrolled in the GENERATION study. 
Methods:The GENERATION study was designed to evaluate, the impact of several 
serum markers (CRP, Lpa. homocystein and seropositivity for chlamydial infection) 
obtained upon admission on the long-term cardiovascular morbidity and mortality and the 
restenosis rate after coronary stenting. For the purpose of this study a total of 463 con- 
secutive patients, treated for stable or unstable coronary syndromes, were recruited 
Complete clinical follow-up was obtained from 465 (96.3%) pts for a period of 3-years. 
Results Of 451 patients with normal pre-intervention CK-MB levels, 39 (391451 6.6%) 
had a peak post-Intervention value >3x normal (without concomitant angina or new elec- 
trocardiographic abnormalities). The number of stents used (p=O.O3), type 8.2 or C 
treated lesions (p=O.OOi) and baseline plasma CRP values (p<O.OOl) were the only sig- 
nificant predictors of CK-MB release. By univariate analysis 3-fold CK-MB release was 
significantly associated with increased risk for the composite endpoint of cardiac death, 
myocardial infarction and rehospitalization for unstable angina (H.R.=2.66, 95%CI=1.62- 
4.37, pcO.001) during the d-years follow up. However, after adjustment for baseline 
plasma CRP values, post-procedural 3.fold CK-MB release did not predict the long-term 
composite endpoint (H.R=0.99 95%Cl=O.53-1.65, p=O.91). 
Conclusion: Elevations in CK-MB following successful CS may reflect the complexity or 
inflammatory status of the treated lesions. These factors may contribute to microembo- 
Ii&ion and subsequent silent myocardial necrosis. Therefore, an increased risk of long- 
term adverse clinical outcomes may be associated with these factors and not the CK-MB 
release per se. 
1175180 Time Relation of the Amount of Macrophages in the 
Plaque During the Chronic Phase of In-Stent Restenosis 
Lodewiik J. Waqenaar, Ad J. van Boven, Allard C. van der Wal, Chris M. van der Loos, 
Rend A. Tio, Anton E. Becker, Wiek H. van Gilst, University Hospital of Groningen, 
Groningen, The Netherlands, Academic Medical Center, Amsterdam, The Netherlands 
Background - Inflammation plays an important role in the acute phase of in-stem resteno- 
sis. But in the chronic phase, after approximately 30 days, the neointimal plaque consist 
mainly of vascular smooth muscle cells. In a previous study, we found that this neointima 
still contains small clusters of macrophages. In this study we Investigated the relation 
between the amount of macrophages in the in-stent restenotic plaque and the time after 
the placement of the stent. Methods - Biopsies from human coronary in-stent restenotic 
lesions were obtained with a pullback atherectomy catheter and immediately frozen in 
liquid nitrogen (n=l9). The time between the placement of the stent and the biopsy varied 
from 69 till 465 days. The biopsies were immunostained for smooth muscle cells, mac- 
rophages and ACE, and a semi-quantitative score was applied: 0 for no macrophages, 1 
for a few or clusters of cells, 2 for <IO% of cells positive, 3 for lo-50% of cells positive 
and 4 for >50% of the cells positive. Results As shown in the figure, an inverse correla- 
tion was found between the amount of macrophages and the time between the biopsy 
and the stent placement (p=O.O13). The macrophages were mostly ACE-positive. There- 
fore, the amount of ACE also decreases during time (p= 0.011). Conclusion - During the 
chronic phase of in-stent restenosis, the amount of macrophages in the neointima 
decreases, as well as the amount of ACE. This Indicates that inflammatory cells play a 
role I” the process of chronic in-stent restenosls. especially in the first phase. 
1175-181 Do Good Collaterals Increase the Risk of Reocclusion 
After Recanalization of a Chronic Coronary Occlusion? 
Gerald S. Werner, Phrlip Bahrmann, Oliver Mutschke. Markds Ferrari, Hans R. Frgulla, 
Friedrich-Schiller Unwersity, Jena, Germany 
Background. The presence of a well developed collateral circulation in chronic coronary 
occlusions (TCO) is considered a potential determinant of reocclusion. The present study 
directly assessed collateral circulation at the time of recanalizatlon by i.c. Doppler and 
pressure recordings I” order to relate it to the risk of reocclusion. 
Methods. In 96 consecutive patients a TCO (duration >2 weeks) was recanalized with 
stenting. Before PTCA average peak velocity distal to the occlusion (APVo). distal coro- 
nary pressure (Po) and aoriic pressure (PAo) were measured, and a collateral resistance 
Index (RcoI, =(P,,-Po)/APVo) was calculated. Collateral function was assessed before 
Reocclusion No reocclusion p-value 
RCa,, [mmHg’cm_ 7.9i4.6 7.5+5.5 0.63 
1 fgl 
CFVR 1.92+0.62 1.96+0.56 0 72 
MLD [mm] 1.91*0.37 2.27t0.51 0.015 
1175-162 Enhanced Suppression of Inflammation After Coronary 
Stenting (ESIS): A Randomized Clinical Trial Comparing 
Abciximab and Eptifibatide 
Atul Aqqarwal, David J. Schneider, Edward F. Terrien, Christopher M. Terrien, Ill, 
Matthew W. Watkins, Samer S. Kabbani, Harold L. Dauerman, University of Vermont 
College of Medicine, Burlington, VT 
Background: Inflammation after coronary stenting portends adverse outcomes. Abcix- 
imab (A) and eptifibatide (E) are reported to alter inflammation after coronary intervention 
but no randomized trial has compared their efficacy. We compared the effect of A and E 
on inflammation after stenting. 
Methods: Patients undergoing coronary stentlng were randomized to treatment with A 
(n=24) or E (n=26). Blood samples were obtained before stenting. and after IO min, 1 hr 
and 16-24 hr. C-reactive protein (CRP.pg/ml), interleukin-6 (IL-6, pglml) and interleukin- 
1 receptor antagonist (IL-1Ra. pglml) were measured by ELISA. Changes in each marker 
after treatment with A or E were analyzed by repeated measure analysis of variance. 
Logarithmic transformation was performed to limit effects of inter-individual variability 
Results: Of the 50 patients enrolled, 66% had acute coronary syndromes. The groups (A 
and E) had similar clinical features, and baseline values of CRP, IL-6, and IL-1 Ra. CRP, 
IL-6 and IL-1Ra increased after stenting despite administration of A or E (see table) and 
comparable increases were seen after each treatment. After logarithmic transformation, 
greater suppression in IL-1Ra but not CRP or IL-6 was seen after E compared with A 
(p=0.03). 
Conclusions: In this randomized trial, inflammation after coronary stenting persists 
despite treatment with A or E. A uniform benefit of one agent wer the other was not 
seen. Enhanced suppressron of inflammation after stenting is a potential therapeutic tar- 
get. 
Before Stenting 10 mrnutes 1 hour 16-24 hours p-value for trend 
CRP (A) 10*19 6.9*16 10+16 13*15 <0.0001 
CRP (E) 6.2+14 6.9*13 10*14 12+15 <0.0001 
IL-6 (A) 5.9t7.4 6.9i8.3 10*12 23i30 <0.0001 
IL-6 (E) 6.7~14 7.6+15 12+21 22i23 <0.0001 
IL-I Ra (A) 546+324 603+310 760+403 672i264 0.0003 
IL-1 Ra (E) 646+496 666+566 711*590 663*505 0.0003 
1175-183 Preprocedural C-Reactive Protein Levels Are Not 
Associated With Restenosis After Successful Coronary 
Stenting: Results From the GENERATION Study 
Michael N. Zairi$ John A. Ambrose, Olga Papadaki, Alexander Stefanidis. Denis Vitalis, 
Stavros Manousakis, Demetrw Petropoulos, Evangelos Tsanis, Evangelos Pissimissis, 
Christopher Olympios. Denis Cokkinos, Stefanos Foussas, Tzamo Hospital, Piraeus, 
Greece, Saint Vincent Medical Centers, Manhattan. New York, NY 
BACKGROUND High plasma C-reactive protein (CRP) levels, has been associated with 
adverse prognosis in pts with coronary artery disease. However, the impact of preproce- 
dual CRP levels on the rate of in-stent restenosis (ISR) after succesful coronary stenting 
(CS) has not been clarified. METHODS The GENERATION study was designed to evaI- 
uate. the impact of several serum markets estimated upon admittance (CRP, Lpa, 
homocystein and seropositivity for chlamydial infection) on the long-term prognosis and 
ISR rate after CS. For the purpose of this study a total of 463 consecutive pabents who 
underwent successful CS due to stable or unstable coronary syndromes were recruited. 
Complete clinical follow up was obtained from 465 (96.3%) pts in a period of 3-years. 
Results: By l-year, 121 patients (121/465 24.1%) developed recurrence of SymptOms. 
During this l-year time period, 309 (309/465 66.5%) patients underwent angiographic 
restudy, tncluding 114 (1 14/121 94.2%) symptomatic and 195 (195/344 55.1%) asymp- 
tomatic. Pts were classified into four groups according to the quartiles of CRP values. 
ISR was observed in 106 (106/309 35%) pts. The distribution of restenosis among the 
quartiles of CRP is presented in the table. There was no statistically increased risk of ISR 
with increasing of CRP quartiles (P=O.69) 
